Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review

Osteoarthritis and Cartilage

Volumn 14, Issue 12, 2006, Pages 1306-1311

  Fernandez Lopez J C ^a   Ruano Ravina, A ^b,c  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b Galician Regional Health Authority   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Hip; Hyaluronic acid; Osteoarthritis; Systematic review

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; HYALURONIC ACID; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ANALGESIA; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EMBASE; EVIDENCE BASED MEDICINE; FOLLOW UP; HIP OSTEOARTHRITIS; HUMAN; INJECTION SITE PAIN; KINESIOTHERAPY; MEDLINE; MOLECULAR WEIGHT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT FAILURE;

HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, HIP; TREATMENT OUTCOME;

EID: 33751195293     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.08.003     Document Type: Article

References (19)

1. Benito-Ruiz P. Artrosis. Etiopatogenia, epidemiología y clasificación. In: Blanco-García F.J., Carreira Delgado P., Martín mola E., Mulero Mendoza J., Navarro Sarabia F., Olivé Marqués A., and Tornero Molina J. (Eds). Manual SER de las Enfermedades Reumáticas (2004), Editorial Médica Panamericana, Madrid 315-319
2. Felson D. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 10 (1988) 1-28
3. Guarda Nardini L., Oliviero F., Ramonda R., and Ferronato G. Influence of intra-articular injections of sodium hyaluronate on clinical features and synovial fluid nitric oxide levels of temporomandibular osteoarthritis. Reumatismo 56 4 (Oct-Dec 2004) 272-277
4. Sato S., Oguri S., Yamaguchi K., Kawamura H., and Motegi K. Pumping injection of sodium hyaluronate for patients with non-reducing disc displacement of the temporomandibular joint: two year follow-up. J Craniomaxillofac Surg 29 2 (Apr 2001) 89-93
5. Poquet Jornet J.E. Utilización del hialuronato en el tratamiento de la osteoartritis. Farm Clin 14 3 (1997) 181-187
6. ACR Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43 (2000) 1905-1915
7. Zhang W., Doherty M., Arden N., Bannwarth B., Bijlsma J., Gunther K.P., et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64 5 (2005) 669-681
8. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd edn. (1996), Williams & Wilkins, Baltimore
9. Bragantini A., and Molinaroli F. A pilot clinical-evaluation of the treatment of hip osteoarthritis with hyaluronic-acid. Curr Ther Res Clin Exp 55 3 (1994) 319-330
10. Brocq O., Tran G., Breuil W., Grisot C., Flory P., and Euller-Ziegler L. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69 4 (2002) 388-391
11. Conrozier T., Bertin P., Mathieu P., Charlot J., Bailleul F., Treves R., et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 21 5 (2003) 605-610
12. Vad V.B., Sakalkale D., Sculco T.P., and Wickiewicz T.L. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84 8 (2003) 1224-1226
13. Berg P., and Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22 3 (2004) 300-306
14. Tikiz C., Unlu Z., Sener A., Efe M., and Tuzun C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 24 3 (2005) 244-250
15. Qvistgaard E., Christensen R., Torp-Pedersen S., and Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 14 1 (2006) 163-170
16. Conrozier T., and Vignon E. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?. Clin Exp Rheumatol 23 5 (2005) 711-716
17. Caglar-Yagci H., Unsal S., Yagci I., Dulgeroglu D., and Ozel S. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25 5 (2005) 341-344
18. Migliore A., Tormenta S., Martin L.S.M., Valente C., Massafra U., Granata M., et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24 3 (2005) 285-289
19. Migliore A., Martin L.M., Valente C., Alimonti A., Villa S., Pistolozzi A., et al. Can we also treat hip osteoarthritis with intra-articular injections of hyaluronic acid? Clinical results of 2 year experience using ultrasound guided intra-articular injections. Gazz Med Ital Arch Sci Med 162 2-3 (2003) 75-83